TLDR
The ADHD telehealth space changed significantly after Done's CEO was arrested (DOJ, June 2024) and Cerebral paid a $7M FTC settlement. This guide covers the remaining trustworthy options for ADHD medication management and therapy — and what to look for when evaluating any telehealth provider.
| Platform | Insurance | Service Type | Legal Status | ADHD-Specialized |
|---|---|---|---|---|
| Talkiatry | Yes (major plans) | Psychiatry + medication | No issues | Partial |
| Brightside | Yes (many states) | Psychiatry + therapy | No issues | No (generalist) |
| Grow Therapy | Yes (most plans) | Therapy only | No issues | No (generalist) |
| Cerebral | Expanding | Therapy + medication | $7M FTC settlement | No (generalist) |
| Done | No | Previously medication-focused | CEO arrested DOJ June 2024 | Yes (was ADHD-specific) |
Talkiatry
Psychiatry-focused telehealth that accepts insurance, uses board-certified psychiatrists, and follows traditional clinical oversight standards.
Pros
- ✓ Accepts major insurance plans — significant cost difference for insured patients
- ✓ Board-certified psychiatrists (not just NPs)
- ✓ Traditional clinical oversight with proper follow-up requirements
- ✓ Available in most US states
Cons
- × Slower process — proper evaluation takes multiple appointments
- × Waitlists in some markets
- × Less convenient than fast-prescribing platforms by design
Pricing: Insurance-dependent; typically $30-100/session after insurance
Verdict: The most rigorously structured option currently available. The slower process is a feature, not a bug — it reflects appropriate clinical standards for prescribing controlled substances.
Brightside
Mental health telehealth covering depression, anxiety, and ADHD. Accepts insurance, has psychiatric and therapy services.
Pros
- ✓ Covers ADHD alongside co-occurring conditions (anxiety, depression)
- ✓ Accepts insurance in many states
- ✓ Combines medication management and therapy options
- ✓ More transparent about clinical approach than some competitors
Cons
- × Not ADHD-specialist — generalist mental health platform
- × Availability varies significantly by state
Pricing: Insurance-dependent; self-pay starts around $95/month
Verdict: Good option if you have co-occurring anxiety or depression alongside ADHD — the ability to address both in one platform is useful. Less specialized than psychiatry-only services.
Grow Therapy
Therapist-matching platform with insurance support. Not a prescribing service — focused on therapy, including ADHD-focused therapy.
Pros
- ✓ Accepts most major insurance plans
- ✓ Broad therapist network with ADHD specialty filters
- ✓ Therapy can complement medication from another provider
Cons
- × No medication management — therapy only
- × Quality varies by individual therapist
- × Not an ADHD-specialist platform
Pricing: Insurance-dependent; self-pay varies by therapist
Verdict: Useful if you have medication management through another provider and need ADHD-focused therapy. Not a standalone ADHD treatment solution.
Cerebral
Broad mental health telehealth that agreed to a $7M FTC settlement in 2024. Still operating, with a shifted focus toward therapy. Acquired Inflow (CBT-based ADHD app) in March 2026.
Pros
- ✓ Now accepts insurance in more markets than before
- ✓ Inflow acquisition brings evidence-based ADHD content
- ✓ Operational changes following FTC settlement
Cons
- × $7M FTC settlement for overprescribing and patient data sharing with advertisers
- × Trust damage from data privacy practices
- × Restructured business model creates uncertainty about continuity
Pricing: Therapy from $95/month; medication management varies
Verdict: Include for completeness. The FTC settlement documented real problems — patient data shared with advertisers and inadequate prescribing oversight. Whether the operational changes are sufficient depends on your risk tolerance.
Done
ADHD-focused telehealth whose CEO was arrested by the DOJ in June 2024 for Adderall distribution fraud. Included for awareness — not currently recommended.
Pros
- ✓ Previously offered fast access to ADHD diagnosis and treatment
Cons
- × CEO arrested June 2024 on DOJ Adderall distribution fraud charges
- × Prescribing practices alleged to be inadequate
- × Operational status uncertain
Pricing: Previously $199/month
Verdict: Not currently recommended. Included here because many former patients are looking for information about what happened and what their options are now. Former patients should transition care to a different provider.
None of these fully work? We know.
Pick a plan to see pricing details and next steps. No card required today.
See plans & pricingWhy This Guide Exists
In June 2024, Done’s CEO was arrested by the DOJ. The same year, Cerebral paid a $7M FTC settlement. Two of the most prominent ADHD telehealth companies faced serious legal action for practices that put patients at risk. The natural question: who’s worth using now?
What the Cases Revealed
Done and Cerebral exposed two different failure modes.
Done allegedly prescribed controlled substances without adequate clinical oversight, prioritizing volume over appropriate care. The DOJ characterized it as a distribution operation, not a clinical practice.
Cerebral shared patient health information — ADHD diagnoses, prescriptions — with advertising networks via tracking pixels. People who sought mental health care had their most sensitive health data used to target them with ads.
Both failures matter when you’re choosing a telehealth provider, because both represent ways the model can be abused.
The Remaining Options
The platforms that didn’t face legal action share certain characteristics: they accept insurance, have traditional clinical oversight, and require multiple visits before prescribing. They’re slower and less convenient than Done was at its fastest. That’s the point.
Who to Consider
Insurance is your priority: Talkiatry and Brightside both accept major plans. You need therapy alongside medication management: Brightside or Grow Therapy. You want the most rigorous oversight: Talkiatry uses board-certified psychiatrists and operates closer to a traditional psychiatry practice.
Q&A
What happened to Done and Cerebral?
Done's CEO was arrested by the Department of Justice in June 2024 on charges related to Adderall distribution fraud — prescribing stimulants without adequate medical oversight. Cerebral agreed to a $7 million FTC settlement for overprescribing controlled substances and sharing patient health data (including diagnosis and prescription information) with advertisers including Facebook and Google via tracking pixels. Both cases highlight specific risks in the telehealth prescribing model.
Q&A
What should I look for in a safe ADHD telehealth provider?
Four indicators: (1) Insurance acceptance — creates accountability structures beyond the platform's own policies. (2) Board-certified psychiatrists for prescribing decisions — not just NPs following algorithms. (3) Multiple visits required before stimulant prescriptions — not same-day prescribing. (4) Clear, specific privacy policy with explicit statements about no advertising pixel tracking. Any platform that makes prescribing very fast and easy should prompt additional scrutiny.
Source: DOJ announcement, June 2024
Source: FTC settlement records
Source: Cerebral acquisition announcement, March 2026
Find a better way to manage your tasks
No credit card. Cancel anytime. Tasks never expire.
Frequently asked